The expression of SMAD3 showed a decreasing trend in type VI plaques, though the difference was not statistically significant (318.3 ± 33.7 vs. 246.3 ± 27.5, p = 0.1851).
← all excerpts
Molecular landscape of atherosclerotic plaque progression: insights from proteomics, single-cell transcriptomics and genomics.
1
—
—